Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.790
-0.010 (-0.56%)
Aug 18, 2026, 10:50 AM EDT - Market open
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $209.71 million as of August 18, 2026. Its market cap has increased by 88.93% in one year.
Market Cap
209.71M
Enterprise Value
190.99M
1-Year Change
88.93%
Ranking
Category
Stock Price
$1.79
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $209.71M, an increase of 200.59%. That is a compound annual growth rate of 15.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 209.71M | 120.57% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anika Therapeutics | 287.73M |
| Akebia Therapeutics | 241.86M |
| Aurora Cannabis | 238.84M |
| Emergent BioSolutions | 235.34M |
| Organogenesis Holdings | 230.33M |
| SIGA Technologies | 215.55M |
| Journey Medical | 185.03M |
| Lifecore Biomedical | 178.67M |